

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.49922210 |
| 2 | protein-chromophore linkage (GO:0018298) | 9.18749335 |
| 3 | * visual perception (GO:0007601) | 8.64019954 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 8.58527567 |
| 5 | * sensory perception of light stimulus (GO:0050953) | 8.53937269 |
| 6 | cellular response to light stimulus (GO:0071482) | 7.65600650 |
| 7 | photoreceptor cell differentiation (GO:0046530) | 7.38000954 |
| 8 | eye photoreceptor cell differentiation (GO:0001754) | 7.38000954 |
| 9 | detection of external stimulus (GO:0009581) | 7.09545484 |
| 10 | detection of abiotic stimulus (GO:0009582) | 6.95419545 |
| 11 | regulation of cGMP metabolic process (GO:0030823) | 6.23858247 |
| 12 | * retina development in camera-type eye (GO:0060041) | 6.00638873 |
| 13 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.58614757 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.32323793 |
| 15 | regulation of cGMP biosynthetic process (GO:0030826) | 5.24501778 |
| 16 | regulation of skeletal muscle contraction (GO:0014819) | 4.96240937 |
| 17 | cellular response to radiation (GO:0071478) | 4.93439418 |
| 18 | positive regulation of cGMP metabolic process (GO:0030825) | 4.92105021 |
| 19 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.82724966 |
| 20 | nonmotile primary cilium assembly (GO:0035058) | 4.79904418 |
| 21 | adaptation of signaling pathway (GO:0023058) | 4.76746376 |
| 22 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.71279696 |
| 23 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.51822362 |
| 24 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.48874451 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.45710786 |
| 26 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.44001713 |
| 27 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.37503044 |
| 28 | actin-myosin filament sliding (GO:0033275) | 4.35696880 |
| 29 | muscle filament sliding (GO:0030049) | 4.35696880 |
| 30 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.04154380 |
| 31 | * sensory perception (GO:0007600) | 4.03008921 |
| 32 | estrogen biosynthetic process (GO:0006703) | 4.00874748 |
| 33 | protein K11-linked deubiquitination (GO:0035871) | 3.98290623 |
| 34 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.96010995 |
| 35 | protein prenylation (GO:0018342) | 3.92226960 |
| 36 | prenylation (GO:0097354) | 3.92226960 |
| 37 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.91643384 |
| 38 | response to light stimulus (GO:0009416) | 3.91187191 |
| 39 | retina layer formation (GO:0010842) | 3.87125232 |
| 40 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.81685310 |
| 41 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.73968970 |
| 42 | actin-mediated cell contraction (GO:0070252) | 3.68332989 |
| 43 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.66168902 |
| 44 | neuron development (GO:0048666) | 3.62932044 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.60387589 |
| 46 | skeletal muscle contraction (GO:0003009) | 3.57189653 |
| 47 | retina homeostasis (GO:0001895) | 3.55553590 |
| 48 | protein localization to synapse (GO:0035418) | 3.50555281 |
| 49 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.43662041 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.41726647 |
| 51 | regulation of cardioblast proliferation (GO:0003264) | 3.35877132 |
| 52 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.35877132 |
| 53 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.32426830 |
| 54 | regulation of female receptivity (GO:0045924) | 3.30084228 |
| 55 | myofibril assembly (GO:0030239) | 3.25266450 |
| 56 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.21742814 |
| 57 | short-term memory (GO:0007614) | 3.19124556 |
| 58 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.18860926 |
| 59 | behavioral response to ethanol (GO:0048149) | 3.12911570 |
| 60 | otic vesicle formation (GO:0030916) | 3.08949864 |
| 61 | retinoid metabolic process (GO:0001523) | 3.07537021 |
| 62 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.07321043 |
| 63 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.05236001 |
| 64 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.04619920 |
| 65 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.04619920 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.03895478 |
| 67 | regulation of meiosis I (GO:0060631) | 3.01869820 |
| 68 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.00195605 |
| 69 | chemosensory behavior (GO:0007635) | 2.99642157 |
| 70 | positive regulation of fatty acid oxidation (GO:0046321) | 2.99624215 |
| 71 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99538739 |
| 72 | opioid receptor signaling pathway (GO:0038003) | 2.99087762 |
| 73 | inner ear receptor stereocilium organization (GO:0060122) | 2.97951950 |
| 74 | phospholipid translocation (GO:0045332) | 2.97125574 |
| 75 | lipid translocation (GO:0034204) | 2.97125574 |
| 76 | regulation of glucokinase activity (GO:0033131) | 2.95592159 |
| 77 | regulation of hexokinase activity (GO:1903299) | 2.95592159 |
| 78 | regulation of penile erection (GO:0060405) | 2.95206600 |
| 79 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92677104 |
| 80 | regulation of energy homeostasis (GO:2000505) | 2.91122958 |
| 81 | protein localization to cell surface (GO:0034394) | 2.90365299 |
| 82 | response to histamine (GO:0034776) | 2.89070051 |
| 83 | synaptic vesicle maturation (GO:0016188) | 2.87113818 |
| 84 | nephron epithelium morphogenesis (GO:0072088) | 2.84850898 |
| 85 | nephron tubule morphogenesis (GO:0072078) | 2.84850898 |
| 86 | diterpenoid metabolic process (GO:0016101) | 2.84794994 |
| 87 | relaxation of cardiac muscle (GO:0055119) | 2.82076739 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.81304009 |
| 89 | kidney morphogenesis (GO:0060993) | 2.81079803 |
| 90 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.80292988 |
| 91 | relaxation of muscle (GO:0090075) | 2.78686503 |
| 92 | axoneme assembly (GO:0035082) | 2.77104900 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.76599366 |
| 94 | energy homeostasis (GO:0097009) | 2.76266939 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.75710320 |
| 96 | neuromuscular synaptic transmission (GO:0007274) | 2.72577268 |
| 97 | striated muscle contraction (GO:0006941) | 2.70376432 |
| 98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.68395514 |
| 99 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.67644306 |
| 100 | response to radiation (GO:0009314) | 2.67621681 |
| 101 | retinol metabolic process (GO:0042572) | 2.67188534 |
| 102 | pancreas development (GO:0031016) | 2.65621318 |
| 103 | lipoprotein transport (GO:0042953) | 2.65607002 |
| 104 | response to pheromone (GO:0019236) | 2.64879151 |
| 105 | nephron tubule formation (GO:0072079) | 2.64469493 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 2.63318408 |
| 107 | female mating behavior (GO:0060180) | 2.62573044 |
| 108 | skeletal muscle fiber development (GO:0048741) | 2.61870965 |
| 109 | innervation (GO:0060384) | 2.61368563 |
| 110 | terpenoid metabolic process (GO:0006721) | 2.60910215 |
| 111 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.60262887 |
| 112 | post-embryonic morphogenesis (GO:0009886) | 2.60248053 |
| 113 | icosanoid secretion (GO:0032309) | 2.59619863 |
| 114 | arachidonic acid secretion (GO:0050482) | 2.59619863 |
| 115 | plasma membrane repair (GO:0001778) | 2.58698447 |
| 116 | negative regulation of cation channel activity (GO:2001258) | 2.56552040 |
| 117 | auditory receptor cell stereocilium organization (GO:0060088) | 2.53929912 |
| 118 | actin filament-based movement (GO:0030048) | 2.52915471 |
| 119 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.52503136 |
| 120 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.52503136 |
| 121 | inositol phosphate catabolic process (GO:0071545) | 2.52116804 |
| 122 | dopamine receptor signaling pathway (GO:0007212) | 2.52036410 |
| 123 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.51520259 |
| 124 | meiotic chromosome segregation (GO:0045132) | 2.51140636 |
| 125 | membrane depolarization during action potential (GO:0086010) | 2.50290585 |
| 126 | cellular potassium ion homeostasis (GO:0030007) | 2.49327671 |
| 127 | cellular response to abiotic stimulus (GO:0071214) | 2.49292768 |
| 128 | musculoskeletal movement (GO:0050881) | 2.48872696 |
| 129 | multicellular organismal movement (GO:0050879) | 2.48872696 |
| 130 | neuron maturation (GO:0042551) | 2.48450701 |
| 131 | dopamine transport (GO:0015872) | 2.46404187 |
| 132 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.46367876 |
| 133 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.46218217 |
| 134 | keratan sulfate catabolic process (GO:0042340) | 2.45602582 |
| 135 | positive regulation of receptor internalization (GO:0002092) | 2.44801667 |
| 136 | renal tubule morphogenesis (GO:0061333) | 2.44082204 |
| 137 | mitochondrion transport along microtubule (GO:0047497) | 2.43882502 |
| 138 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.43882502 |
| 139 | endocardial cushion morphogenesis (GO:0003203) | 2.43334973 |
| 140 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.42626780 |
| 141 | muscle cell fate commitment (GO:0042693) | 2.42426800 |
| 142 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.41801663 |
| 143 | dentate gyrus development (GO:0021542) | 2.41239082 |
| 144 | regulation of fatty acid oxidation (GO:0046320) | 2.40474192 |
| 145 | ketone body metabolic process (GO:1902224) | 2.38917564 |
| 146 | muscle contraction (GO:0006936) | 2.38712967 |
| 147 | protein heterotetramerization (GO:0051290) | 2.37872871 |
| 148 | regulation of cell communication by electrical coupling (GO:0010649) | 2.37352348 |
| 149 | coenzyme catabolic process (GO:0009109) | 2.37018251 |
| 150 | behavioral response to nicotine (GO:0035095) | 2.36657632 |
| 151 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.36368619 |
| 152 | sodium ion export (GO:0071436) | 2.35959968 |
| 153 | spinal cord motor neuron differentiation (GO:0021522) | 2.35917882 |
| 154 | positive regulation of meiosis (GO:0045836) | 2.35128456 |
| 155 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.33889703 |
| 156 | response to hepatocyte growth factor (GO:0035728) | 2.33889703 |
| 157 | cellular response to electrical stimulus (GO:0071257) | 2.33444423 |
| 158 | skeletal muscle tissue development (GO:0007519) | 2.33252780 |
| 159 | positive regulation of cyclase activity (GO:0031281) | 2.33046180 |
| 160 | behavioral response to cocaine (GO:0048148) | 2.32681736 |
| 161 | myotube cell development (GO:0014904) | 2.32184778 |
| 162 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.31012051 |
| 163 | positive regulation of gluconeogenesis (GO:0045722) | 2.30799229 |
| 164 | phosphate ion homeostasis (GO:0055062) | 2.30537267 |
| 165 | trivalent inorganic anion homeostasis (GO:0072506) | 2.30537267 |
| 166 | cardiac myofibril assembly (GO:0055003) | 2.30498086 |
| 167 | response to muscle activity (GO:0014850) | 2.28722270 |
| 168 | regulation of protein glycosylation (GO:0060049) | 2.28415202 |
| 169 | regulation of relaxation of muscle (GO:1901077) | 2.28070752 |
| 170 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.5236148 |
| 171 | rhodopsin mediated signaling pathway (GO:0016056) | 18.1087588 |
| 172 | retinal cone cell development (GO:0046549) | 14.4670812 |
| 173 | photoreceptor cell development (GO:0042461) | 12.3217456 |
| 174 | photoreceptor cell maintenance (GO:0045494) | 12.1410797 |
| 175 | eye photoreceptor cell development (GO:0042462) | 11.6660256 |
| 176 | detection of light stimulus involved in visual perception (GO:0050908) | 11.0774158 |
| 177 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.0774158 |
| 178 | phototransduction (GO:0007602) | 10.7151867 |
| 179 | phototransduction, visible light (GO:0007603) | 10.6472705 |
| 180 | GMP metabolic process (GO:0046037) | 10.4538262 |
| 181 | detection of light stimulus (GO:0009583) | 10.1653920 |
| 182 | detection of visible light (GO:0009584) | 10.1368068 |
| 183 | retinal rod cell development (GO:0046548) | 10.0940884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.52809242 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36275766 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.48451049 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.27277965 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.84980105 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.58839930 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.58798515 |
| 8 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.53412666 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.49601504 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39608621 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34105967 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13473363 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13140117 |
| 14 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.03118709 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97289629 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90629150 |
| 17 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89308336 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.87180807 |
| 19 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.84621695 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82082287 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.81082852 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81002806 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80868186 |
| 24 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.72443223 |
| 25 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72443223 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72433078 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.71595061 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71439161 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65720981 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64723485 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63872082 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.61159660 |
| 33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60250155 |
| 34 | AR_19668381_ChIP-Seq_PC3_Human | 1.59162713 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57561311 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54274347 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53557349 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51112232 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50481780 |
| 40 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.47101264 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45684248 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45317665 |
| 43 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.45009018 |
| 44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44359666 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42743121 |
| 46 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.42006599 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.41425419 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41180423 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40904441 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38602878 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37850149 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37169819 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37092521 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36775371 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35837098 |
| 56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.34805425 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34356299 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33210793 |
| 59 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33135605 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32766103 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32766103 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31742160 |
| 63 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.30669217 |
| 64 | TBL1_22424771_ChIP-Seq_293T_Human | 1.29869789 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29034277 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28648904 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28523856 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28523856 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28086179 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27189601 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27102248 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25965384 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25117362 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24900454 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24787321 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24263644 |
| 77 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.23125382 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22494225 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21719340 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21407198 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20646390 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20556769 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20548752 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20044634 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19988569 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.19357650 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19215088 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18959441 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18751197 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18734998 |
| 91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18637210 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17785669 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17138814 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17020609 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16093641 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16053224 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15915365 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15684731 |
| 99 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.15098281 |
| 100 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14818049 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14714113 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14583428 |
| 103 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.14371012 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13684137 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13177802 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12422081 |
| 107 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12068155 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 1.12057709 |
| 109 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12050020 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11863358 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11644620 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11644620 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11325266 |
| 114 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11285927 |
| 115 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.10308375 |
| 116 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10063091 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09597260 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09475488 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09382216 |
| 120 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.08887104 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08877299 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08873691 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08583521 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08279585 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07545919 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07545919 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07227581 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06980828 |
| 129 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06043991 |
| 130 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05536532 |
| 131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05394928 |
| 132 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05265138 |
| 133 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03605089 |
| 134 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03122490 |
| 135 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02896005 |
| 136 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02729841 |
| 137 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02402255 |
| 138 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.01666704 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 1.01041094 |
| 140 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00833848 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99318547 |
| 142 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96706550 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96389667 |
| 144 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96323710 |
| 145 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95712272 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95702957 |
| 147 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95301797 |
| 148 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92504900 |
| 149 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92390876 |
| 150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91783065 |
| 151 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91735966 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90840295 |
| 153 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90229647 |
| 154 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89599964 |
| 155 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87739452 |
| 156 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.87721653 |
| 157 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87600917 |
| 158 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87175020 |
| 159 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.86976136 |
| 160 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86049557 |
| 161 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85041749 |
| 162 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84622249 |
| 163 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84606982 |
| 164 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84208404 |
| 165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.82851096 |
| 166 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82469783 |
| 167 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81992510 |
| 168 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.81835963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.71796302 |
| 2 | * MP0005253_abnormal_eye_physiology | 6.70117034 |
| 3 | * MP0006072_abnormal_retinal_apoptosis | 5.49698997 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.22562357 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.89545980 |
| 6 | * MP0005391_vision/eye_phenotype | 3.24846087 |
| 7 | * MP0001324_abnormal_eye_pigmentation | 3.22988961 |
| 8 | MP0005503_abnormal_tendon_morphology | 3.15628423 |
| 9 | MP0002638_abnormal_pupillary_reflex | 3.03713273 |
| 10 | MP0002090_abnormal_vision | 3.01713818 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.71049412 |
| 12 | MP0002229_neurodegeneration | 2.68450793 |
| 13 | MP0003195_calcinosis | 2.41400798 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.38733502 |
| 15 | MP0001764_abnormal_homeostasis | 2.19991772 |
| 16 | MP0000749_muscle_degeneration | 2.18350825 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.00078290 |
| 18 | MP0003011_delayed_dark_adaptation | 11.5777776 |
| 19 | MP0005275_abnormal_skin_tensile | 1.94362075 |
| 20 | * MP0002752_abnormal_somatic_nervous | 1.90427458 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.89916268 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.84974708 |
| 23 | MP0000372_irregular_coat_pigmentation | 1.79819087 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.62523351 |
| 25 | MP0005369_muscle_phenotype | 1.60664396 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.59640398 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.58087693 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.57356697 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.53588815 |
| 30 | MP0002163_abnormal_gland_morphology | 1.51037667 |
| 31 | MP0003879_abnormal_hair_cell | 1.49292740 |
| 32 | MP0004130_abnormal_muscle_cell | 1.48212417 |
| 33 | MP0004484_altered_response_of | 1.47993550 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.42452795 |
| 35 | * MP0002882_abnormal_neuron_morphology | 1.39157551 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.37394908 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.29955026 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.27426019 |
| 39 | MP0001664_abnormal_digestion | 1.25508056 |
| 40 | MP0001756_abnormal_urination | 1.23750831 |
| 41 | MP0004233_abnormal_muscle_weight | 1.22519592 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.21636880 |
| 43 | MP0001944_abnormal_pancreas_morphology | 1.20699747 |
| 44 | MP0000747_muscle_weakness | 1.17264320 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.17080626 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.15727255 |
| 47 | MP0003122_maternal_imprinting | 1.15663559 |
| 48 | MP0004885_abnormal_endolymph | 1.11512844 |
| 49 | MP0002269_muscular_atrophy | 1.07297146 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.07026566 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.05278978 |
| 52 | MP0005197_abnormal_uvea_morphology | 1.04084194 |
| 53 | MP0003136_yellow_coat_color | 1.03833556 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.03675961 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.03000993 |
| 56 | MP0002132_abnormal_respiratory_system | 1.02973446 |
| 57 | MP0001984_abnormal_olfaction | 1.02803629 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.00430176 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.96640128 |
| 60 | MP0004270_analgesia | 0.95330890 |
| 61 | MP0002896_abnormal_bone_mineralization | 0.93706393 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.93280005 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.92017868 |
| 64 | MP0002972_abnormal_cardiac_muscle | 0.91779291 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.91138922 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.89495944 |
| 67 | MP0005394_taste/olfaction_phenotype | 0.87351137 |
| 68 | MP0005499_abnormal_olfactory_system | 0.87351137 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.86966306 |
| 70 | MP0005187_abnormal_penis_morphology | 0.83846387 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 0.83667078 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.83247574 |
| 73 | MP0006292_abnormal_olfactory_placode | 0.83239137 |
| 74 | MP0001486_abnormal_startle_reflex | 0.81215341 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.81210801 |
| 76 | MP0003878_abnormal_ear_physiology | 0.81210801 |
| 77 | MP0005332_abnormal_amino_acid | 0.80348902 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.78865564 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 0.77213818 |
| 80 | MP0008775_abnormal_heart_ventricle | 0.76331316 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.74901472 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 0.74695545 |
| 83 | MP0008872_abnormal_physiological_respon | 0.74417290 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.74064870 |
| 85 | MP0005385_cardiovascular_system_phenoty | 0.74064870 |
| 86 | MP0002272_abnormal_nervous_system | 0.73611447 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.72599380 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.71315508 |
| 89 | MP0003880_abnormal_central_pattern | 0.68579382 |
| 90 | * MP0003634_abnormal_glial_cell | 0.66228149 |
| 91 | MP0004859_abnormal_synaptic_plasticity | 0.60656172 |
| 92 | MP0002064_seizures | 0.56447257 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 0.55352303 |
| 94 | MP0009046_muscle_twitch | 0.54028141 |
| 95 | MP0003635_abnormal_synaptic_transmissio | 0.52679925 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.49486240 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.49272475 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.46501307 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.42326070 |
| 100 | MP0002063_abnormal_learning/memory/cond | 0.41204884 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.40484703 |
| 102 | MP0003045_fibrosis | 0.37001677 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.35903390 |
| 104 | MP0002572_abnormal_emotion/affect_behav | 0.35630798 |
| 105 | MP0004924_abnormal_behavior | 0.34784692 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.34784692 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 0.33929308 |
| 108 | MP0009745_abnormal_behavioral_response | 0.32829492 |
| 109 | * MP0001286_abnormal_eye_development | 0.32552166 |
| 110 | MP0004085_abnormal_heartbeat | 0.31921965 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.31672483 |
| 112 | MP0001968_abnormal_touch/_nociception | 0.31369351 |
| 113 | MP0002697_abnormal_eye_size | 0.31014232 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.30212124 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.29341950 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.28789336 |
| 117 | MP0004043_abnormal_pH_regulation | 0.27308781 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.27176142 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.27116499 |
| 120 | MP0001915_intracranial_hemorrhage | 0.26043095 |
| 121 | MP0005193_abnormal_anterior_eye | 0.25665425 |
| 122 | MP0000026_abnormal_inner_ear | 0.25446149 |
| 123 | MP0008569_lethality_at_weaning | 0.25255479 |
| 124 | MP0002152_abnormal_brain_morphology | 0.24127633 |
| 125 | MP0003252_abnormal_bile_duct | 0.23227558 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.22894827 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.22808470 |
| 128 | MP0004742_abnormal_vestibular_system | 0.22704136 |
| 129 | MP0004142_abnormal_muscle_tone | 0.22407920 |
| 130 | MP0008004_abnormal_stomach_pH | 0.22018035 |
| 131 | MP0004811_abnormal_neuron_physiology | 0.21995774 |
| 132 | MP0002928_abnormal_bile_duct | 0.21889096 |
| 133 | MP0002184_abnormal_innervation | 0.21749820 |
| 134 | MP0000751_myopathy | 0.20659727 |
| 135 | MP0001661_extended_life_span | 0.20603977 |
| 136 | MP0002102_abnormal_ear_morphology | 0.20503896 |
| 137 | MP0010386_abnormal_urinary_bladder | 0.19501470 |
| 138 | MP0003646_muscle_fatigue | 0.18990594 |
| 139 | MP0003632_abnormal_nervous_system | 0.18734279 |
| 140 | MP0003633_abnormal_nervous_system | 0.17371886 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.17165821 |
| 142 | MP0002108_abnormal_muscle_morphology | 0.16910947 |
| 143 | MP0003943_abnormal_hepatobiliary_system | 0.15222577 |
| 144 | MP0000778_abnormal_nervous_system | 0.15197296 |
| 145 | MP0005330_cardiomyopathy | 0.15039219 |
| 146 | MP0010030_abnormal_orbit_morphology | 0.14528299 |
| 147 | MP0003631_nervous_system_phenotype | 0.13150787 |
| 148 | MP0002909_abnormal_adrenal_gland | 0.12519271 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.11949597 |
| 150 | MP0001905_abnormal_dopamine_level | 0.10923765 |
| 151 | MP0003137_abnormal_impulse_conducting | 0.10140780 |
| 152 | MP0004036_abnormal_muscle_relaxation | 0.09866987 |
| 153 | MP0001177_atelectasis | 0.09803589 |
| 154 | MP0002557_abnormal_social/conspecific_i | 0.09384823 |
| 155 | MP0003956_abnormal_body_size | 0.08692055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chorioretinal atrophy (HP:0000533) | 9.30222289 |
| 2 | Central scotoma (HP:0000603) | 8.81186381 |
| 3 | Pendular nystagmus (HP:0012043) | 8.00176747 |
| 4 | Dyschromatopsia (HP:0007641) | 7.87285129 |
| 5 | Scotoma (HP:0000575) | 7.84348776 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.82901509 |
| 7 | Attenuation of retinal blood vessels (HP:0007843) | 7.77338385 |
| 8 | * Pigmentary retinal degeneration (HP:0001146) | 7.35618390 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 6.96990773 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 6.48305451 |
| 11 | Decreased central vision (HP:0007663) | 6.32714220 |
| 12 | Nemaline bodies (HP:0003798) | 6.18180572 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.03570915 |
| 14 | * Type II diabetes mellitus (HP:0005978) | 5.65882429 |
| 15 | * Photophobia (HP:0000613) | 5.59212871 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 5.43180533 |
| 17 | Macular degeneration (HP:0000608) | 5.18960934 |
| 18 | Increased corneal curvature (HP:0100692) | 5.17039097 |
| 19 | Keratoconus (HP:0000563) | 5.17039097 |
| 20 | Cone-rod dystrophy (HP:0000548) | 5.12842812 |
| 21 | Vitreoretinal degeneration (HP:0000655) | 5.07092094 |
| 22 | Posterior subcapsular cataract (HP:0007787) | 4.95346631 |
| 23 | Severe visual impairment (HP:0001141) | 4.77310704 |
| 24 | Constricted visual fields (HP:0001133) | 4.55907856 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 4.43608826 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.37055711 |
| 27 | * Retinitis pigmentosa (HP:0000510) | 4.25619613 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 4.05895275 |
| 29 | Exercise-induced myalgia (HP:0003738) | 3.99665449 |
| 30 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.83524096 |
| 31 | Distal arthrogryposis (HP:0005684) | 3.66547405 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.46117325 |
| 33 | Hypoplasia of the uterus (HP:0000013) | 3.41136977 |
| 34 | Progressive visual loss (HP:0000529) | 3.30772275 |
| 35 | Round ear (HP:0100830) | 3.19226570 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 3.16284267 |
| 37 | Retinal atrophy (HP:0001105) | 3.06628883 |
| 38 | Intestinal atresia (HP:0011100) | 3.05117097 |
| 39 | Subcapsular cataract (HP:0000523) | 3.02715728 |
| 40 | Metaphyseal dysplasia (HP:0100255) | 2.80399020 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.67084959 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 2.66554660 |
| 43 | Optic disc pallor (HP:0000543) | 2.61588819 |
| 44 | Hemiparesis (HP:0001269) | 2.61437554 |
| 45 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.60403340 |
| 46 | Hyperkalemia (HP:0002153) | 2.60088575 |
| 47 | Myoglobinuria (HP:0002913) | 2.58643970 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.52905087 |
| 49 | * Wide nasal bridge (HP:0000431) | 2.51361188 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50657257 |
| 51 | Myopathic facies (HP:0002058) | 2.49603807 |
| 52 | Frequent falls (HP:0002359) | 2.47414809 |
| 53 | Wrist flexion contracture (HP:0001239) | 2.45141553 |
| 54 | Rhabdomyolysis (HP:0003201) | 2.38995379 |
| 55 | Gait imbalance (HP:0002141) | 2.38754807 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.36652270 |
| 57 | Absent frontal sinuses (HP:0002688) | 2.33665047 |
| 58 | Arthropathy (HP:0003040) | 2.33211212 |
| 59 | Mesangial abnormality (HP:0001966) | 2.33094128 |
| 60 | * Choroideremia (HP:0001139) | 2.32964173 |
| 61 | Hypoplastic ischia (HP:0003175) | 2.29078192 |
| 62 | Absent phalangeal crease (HP:0006109) | 2.24872942 |
| 63 | Congenital malformation of the right heart (HP:0011723) | 2.22735900 |
| 64 | Double outlet right ventricle (HP:0001719) | 2.22735900 |
| 65 | Tubular atrophy (HP:0000092) | 2.18188702 |
| 66 | Ulnar deviation of the wrist (HP:0003049) | 2.17703680 |
| 67 | Muscle fiber splitting (HP:0003555) | 2.17676562 |
| 68 | Hamartoma of the eye (HP:0010568) | 2.13182809 |
| 69 | Hypomagnesemia (HP:0002917) | 2.12944526 |
| 70 | Ketoacidosis (HP:0001993) | 2.12302373 |
| 71 | Infantile muscular hypotonia (HP:0008947) | 2.10525427 |
| 72 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08858047 |
| 73 | Calcaneovalgus deformity (HP:0001848) | 2.07052363 |
| 74 | Deformed tarsal bones (HP:0008119) | 2.04006873 |
| 75 | Late onset (HP:0003584) | 2.03808827 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.01009316 |
| 77 | Congenital stationary night blindness (HP:0007642) | 14.9199390 |
| 78 | Bony spicule pigmentary retinopathy (HP:0007737) | 12.2312534 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.6602406 |
| 80 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.4232951 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 1.99091359 |
| 82 | Abnormality of the ischium (HP:0003174) | 1.93995415 |
| 83 | Persistence of primary teeth (HP:0006335) | 1.92416707 |
| 84 | Hyperglycemia (HP:0003074) | 1.88946631 |
| 85 | Abnormality of the vitreous humor (HP:0004327) | 1.87282826 |
| 86 | Sudden death (HP:0001699) | 1.86111779 |
| 87 | Slender build (HP:0001533) | 1.81894810 |
| 88 | Increased circulating renin level (HP:0000848) | 1.81719130 |
| 89 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80579193 |
| 90 | Poor coordination (HP:0002370) | 1.80331395 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 1.78859418 |
| 92 | Malignant hyperthermia (HP:0002047) | 1.78113009 |
| 93 | Focal seizures (HP:0007359) | 1.77728213 |
| 94 | Large for gestational age (HP:0001520) | 1.73427964 |
| 95 | Hip contracture (HP:0003273) | 1.72836889 |
| 96 | Thyroid-stimulating hormone excess (HP:0002925) | 1.71959050 |
| 97 | Dialeptic seizures (HP:0011146) | 1.71830656 |
| 98 | Abnormal drinking behavior (HP:0030082) | 1.71633389 |
| 99 | Polydipsia (HP:0001959) | 1.71633389 |
| 100 | Hyperphosphatemia (HP:0002905) | 1.71426652 |
| 101 | Abnormality of lateral ventricle (HP:0030047) | 1.71279058 |
| 102 | Action tremor (HP:0002345) | 1.71135387 |
| 103 | Abnormal pancreas size (HP:0012094) | 1.70727912 |
| 104 | Abnormal finger flexion creases (HP:0006143) | 1.67572902 |
| 105 | Polar cataract (HP:0010696) | 1.67438612 |
| 106 | Abnormality of potassium homeostasis (HP:0011042) | 1.65642311 |
| 107 | Delayed gross motor development (HP:0002194) | 1.64861304 |
| 108 | Testicular neoplasm (HP:0010788) | 1.64526180 |
| 109 | Abnormality of magnesium homeostasis (HP:0004921) | 1.64340257 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 1.63780389 |
| 111 | Bundle branch block (HP:0011710) | 1.63521442 |
| 112 | Myotonia (HP:0002486) | 1.63451213 |
| 113 | Subacute progressive viral hepatitis (HP:0006572) | 1.63257935 |
| 114 | Subaortic stenosis (HP:0001682) | 1.63196831 |
| 115 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.63196831 |
| 116 | Vaginal atresia (HP:0000148) | 1.63039260 |
| 117 | Popliteal pterygium (HP:0009756) | 1.62895102 |
| 118 | * Optic atrophy (HP:0000648) | 1.61231266 |
| 119 | Genital tract atresia (HP:0001827) | 1.55808162 |
| 120 | Horizontal nystagmus (HP:0000666) | 1.53607994 |
| 121 | True hermaphroditism (HP:0010459) | 1.41459459 |
| 122 | Severe Myopia (HP:0011003) | 1.36211420 |
| 123 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.35360401 |
| 124 | Dysdiadochokinesis (HP:0002075) | 1.30982825 |
| 125 | Pancreatic fibrosis (HP:0100732) | 1.28238257 |
| 126 | Abnormality of the fovea (HP:0000493) | 1.23430759 |
| 127 | Epileptic encephalopathy (HP:0200134) | 1.18462692 |
| 128 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.15872187 |
| 129 | Hypoplasia of the fovea (HP:0007750) | 1.15872187 |
| 130 | Astigmatism (HP:0000483) | 1.09528140 |
| 131 | Cystic liver disease (HP:0006706) | 1.08893205 |
| 132 | Recurrent sinusitis (HP:0011108) | 1.03356634 |
| 133 | Pancreatic cysts (HP:0001737) | 1.02144703 |
| 134 | Visual hallucinations (HP:0002367) | 0.99313045 |
| 135 | Febrile seizures (HP:0002373) | 0.97937954 |
| 136 | Specific learning disability (HP:0001328) | 0.97844106 |
| 137 | Left ventricular hypertrophy (HP:0001712) | 0.97262362 |
| 138 | Broad foot (HP:0001769) | 0.96579928 |
| 139 | Truncal ataxia (HP:0002078) | 0.95303540 |
| 140 | Cerebellar dysplasia (HP:0007033) | 0.94670672 |
| 141 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.94028081 |
| 142 | Chorioretinal coloboma (HP:0000567) | 0.92867263 |
| 143 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.91397603 |
| 144 | Decreased testicular size (HP:0008734) | 0.91031127 |
| 145 | Progressive cerebellar ataxia (HP:0002073) | 0.89544406 |
| 146 | Asthma (HP:0002099) | 0.89366035 |
| 147 | Sclerocornea (HP:0000647) | 0.88414999 |
| 148 | Hypermetropia (HP:0000540) | 0.88343613 |
| 149 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.85141096 |
| 150 | Furrowed tongue (HP:0000221) | 0.78928480 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.78255029 |
| 152 | Prolonged QT interval (HP:0001657) | 0.73734627 |
| 153 | * Retinal detachment (HP:0000541) | 0.73158048 |
| 154 | Partial agenesis of the corpus callosum (HP:0001338) | 0.71199816 |
| 155 | Genetic anticipation (HP:0003743) | 0.70737867 |
| 156 | Abnormality of midbrain morphology (HP:0002418) | 0.70162711 |
| 157 | Molar tooth sign on MRI (HP:0002419) | 0.70162711 |
| 158 | Abnormality of dental color (HP:0011073) | 0.68350232 |
| 159 | Lymphopenia (HP:0001888) | 0.65625215 |
| 160 | Dental crowding (HP:0000678) | 0.65382225 |
| 161 | Hypodontia (HP:0000668) | 0.65228303 |
| 162 | Postaxial hand polydactyly (HP:0001162) | 0.63828167 |
| 163 | Short foot (HP:0001773) | 0.63569919 |
| 164 | Anencephaly (HP:0002323) | 0.63148624 |
| 165 | Chronic hepatic failure (HP:0100626) | 0.62469759 |
| 166 | Macroorchidism (HP:0000053) | 0.61394531 |
| 167 | Congenital hepatic fibrosis (HP:0002612) | 0.59645463 |
| 168 | Abnormality of the fingertips (HP:0001211) | 0.59359641 |
| 169 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.59062551 |
| 170 | Generalized myoclonic seizures (HP:0002123) | 0.59002466 |
| 171 | Depression (HP:0000716) | 0.58965320 |
| 172 | Hypoventilation (HP:0002791) | 0.58620054 |
| 173 | Abnormal EKG (HP:0003115) | 0.58325189 |
| 174 | Abnormality of the lower motor neuron (HP:0002366) | 0.58007484 |
| 175 | Broad-based gait (HP:0002136) | 0.56710327 |
| 176 | Postural instability (HP:0002172) | 0.56590486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.94348699 |
| 2 | OBSCN | 5.14476964 |
| 3 | PINK1 | 3.28786576 |
| 4 | IRAK2 | 2.67611482 |
| 5 | ADRBK2 | 2.43213607 |
| 6 | NLK | 2.32237420 |
| 7 | FGFR2 | 2.30644264 |
| 8 | GRK1 | 11.2427942 |
| 9 | PIK3CG | 1.97014791 |
| 10 | MAP3K10 | 1.88306409 |
| 11 | MST4 | 1.84699653 |
| 12 | TTN | 1.78692603 |
| 13 | BLK | 1.75004070 |
| 14 | SIK2 | 1.65880147 |
| 15 | FER | 1.65307612 |
| 16 | DAPK2 | 1.59286456 |
| 17 | CAMK1G | 1.49649106 |
| 18 | WNK3 | 1.48318180 |
| 19 | ADRBK1 | 1.45778212 |
| 20 | PAK6 | 1.42243799 |
| 21 | CDK12 | 1.36525903 |
| 22 | FGFR3 | 1.35472627 |
| 23 | MAPK7 | 1.34607902 |
| 24 | TAOK3 | 1.30327122 |
| 25 | LMTK2 | 1.29744273 |
| 26 | IRAK1 | 1.28376646 |
| 27 | MAPK12 | 1.28108269 |
| 28 | MAP4K2 | 1.27671366 |
| 29 | NEK1 | 1.25942846 |
| 30 | EPHB1 | 1.25816742 |
| 31 | BRD4 | 1.25620212 |
| 32 | CAMK1D | 1.23390536 |
| 33 | HIPK2 | 1.22033973 |
| 34 | INSRR | 1.20524215 |
| 35 | CSNK1G1 | 1.19458332 |
| 36 | MAP3K12 | 1.19167054 |
| 37 | SGK223 | 1.18442475 |
| 38 | SGK494 | 1.18442475 |
| 39 | STK38 | 1.18118527 |
| 40 | PKN2 | 1.16971769 |
| 41 | MUSK | 1.16087240 |
| 42 | ICK | 1.15450024 |
| 43 | MAP2K6 | 1.13471220 |
| 44 | TRPM7 | 1.13378378 |
| 45 | PRKD3 | 1.12587461 |
| 46 | MARK1 | 1.11210318 |
| 47 | RPS6KA4 | 1.08770512 |
| 48 | PNCK | 1.05822310 |
| 49 | MAP3K4 | 1.05745456 |
| 50 | CSNK1D | 1.04243280 |
| 51 | PRKCE | 1.03037607 |
| 52 | ERBB2 | 1.02074130 |
| 53 | PRKCH | 1.00236658 |
| 54 | FLT3 | 1.00221647 |
| 55 | TNIK | 1.00017486 |
| 56 | EPHA4 | 0.96996846 |
| 57 | PRKCZ | 0.96021079 |
| 58 | CAMKK2 | 0.88013424 |
| 59 | SGK2 | 0.87635379 |
| 60 | CAMKK1 | 0.87560200 |
| 61 | SGK3 | 0.82648689 |
| 62 | WNK1 | 0.78628423 |
| 63 | CSNK1G2 | 0.76967553 |
| 64 | CCNB1 | 0.76068712 |
| 65 | GSK3A | 0.73849770 |
| 66 | PRKAA1 | 0.73739869 |
| 67 | ROCK1 | 0.73437130 |
| 68 | AKT3 | 0.73375322 |
| 69 | PRKG2 | 0.72206822 |
| 70 | DYRK1A | 0.72116106 |
| 71 | PTK2B | 0.71863912 |
| 72 | PRKCB | 0.70347392 |
| 73 | GRK5 | 0.68304886 |
| 74 | CAMK2D | 0.65203281 |
| 75 | PRKACG | 0.62629626 |
| 76 | DYRK2 | 0.62545037 |
| 77 | NEK2 | 0.60117936 |
| 78 | MAP3K13 | 0.59596016 |
| 79 | PAK3 | 0.59560128 |
| 80 | MAPKAPK5 | 0.59485733 |
| 81 | MAPKAPK3 | 0.59212839 |
| 82 | TTK | 0.59184041 |
| 83 | DYRK1B | 0.59019917 |
| 84 | RPS6KA3 | 0.59015417 |
| 85 | PRKAA2 | 0.58037214 |
| 86 | MKNK2 | 0.57562532 |
| 87 | DYRK3 | 0.55239908 |
| 88 | CAMK2G | 0.55200463 |
| 89 | SCYL2 | 0.54764204 |
| 90 | CDK3 | 0.54666434 |
| 91 | FES | 0.54490715 |
| 92 | PLK2 | 0.53791693 |
| 93 | PHKG2 | 0.53090152 |
| 94 | PHKG1 | 0.53090152 |
| 95 | PRKD2 | 0.52973842 |
| 96 | PRKG1 | 0.52150250 |
| 97 | NUAK1 | 0.51914658 |
| 98 | MAP3K1 | 0.51856517 |
| 99 | BMPR1B | 0.51792367 |
| 100 | PDK1 | 0.51493306 |
| 101 | LATS1 | 0.48867669 |
| 102 | SGK1 | 0.48222425 |
| 103 | MAPK13 | 0.47699136 |
| 104 | CAMK1 | 0.47063071 |
| 105 | OXSR1 | 0.46627021 |
| 106 | CDK5 | 0.46431777 |
| 107 | PRKDC | 0.45973194 |
| 108 | GSK3B | 0.45020082 |
| 109 | MAP2K7 | 0.44419607 |
| 110 | SIK1 | 0.44329037 |
| 111 | MAPK9 | 0.42631422 |
| 112 | CDK9 | 0.42313671 |
| 113 | MAP3K7 | 0.42028065 |
| 114 | MAPK14 | 0.41811692 |
| 115 | STK3 | 0.41685597 |
| 116 | MINK1 | 0.41055293 |
| 117 | AKT2 | 0.40513922 |
| 118 | MAPK10 | 0.40097602 |
| 119 | NEK6 | 0.40046890 |
| 120 | CSNK1A1 | 0.38838974 |
| 121 | CSNK1G3 | 0.38224978 |
| 122 | CAMK4 | 0.37807396 |
| 123 | PLK3 | 0.37490139 |
| 124 | STK11 | 0.36667903 |
| 125 | CAMK2A | 0.35920513 |
| 126 | TIE1 | 0.35047306 |
| 127 | MYLK | 0.34620628 |
| 128 | MAP2K4 | 0.34142012 |
| 129 | CDK1 | 0.34108871 |
| 130 | PRKCG | 0.34011535 |
| 131 | ALK | 0.32879239 |
| 132 | EPHA3 | 0.31122643 |
| 133 | PRKACA | 0.30585292 |
| 134 | PKN1 | 0.29888033 |
| 135 | RPS6KB1 | 0.28878209 |
| 136 | FGFR4 | 0.27485156 |
| 137 | FRK | 0.27467722 |
| 138 | MAPK15 | 0.27079310 |
| 139 | PRKCA | 0.26632502 |
| 140 | STK39 | 0.26473379 |
| 141 | MAP2K1 | 0.26412905 |
| 142 | CSNK1E | 0.25115502 |
| 143 | CDC42BPA | 0.23442966 |
| 144 | NTRK3 | 0.22497589 |
| 145 | WNK4 | 0.22384009 |
| 146 | MAPK8 | 0.22369687 |
| 147 | PIK3CA | 0.22257673 |
| 148 | ATM | 0.20474551 |
| 149 | CHEK2 | 0.20370036 |
| 150 | PDK2 | 0.20255903 |
| 151 | PRKD1 | 0.18380650 |
| 152 | NTRK2 | 0.18230473 |
| 153 | CHEK1 | 0.18225727 |
| 154 | MAPK3 | 0.18145010 |
| 155 | MAP3K9 | 0.18063089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.03524041 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 15.8970636 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94263502 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68305616 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.67010037 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.66417150 |
| 7 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.58542166 |
| 8 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.52011597 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50464700 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48014995 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43319349 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42966065 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34230507 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33560334 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.27661651 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26517853 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24884974 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21573296 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.14274789 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05200708 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02252500 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93072957 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92919237 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92774609 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90681763 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88283109 |
| 27 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87833182 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87773562 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86530604 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84996337 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 0.83108350 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82395826 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80227709 |
| 34 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79988259 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79863520 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79789101 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76767594 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73754483 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72327487 |
| 40 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71674616 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70508386 |
| 42 | Melanoma_Homo sapiens_hsa05218 | 0.69461402 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67634312 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66867392 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.66851469 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65971134 |
| 47 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62285135 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61275308 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60738270 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60680658 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57289022 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57252007 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.56640709 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54800969 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54619549 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52726930 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52656772 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52426598 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.50565299 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50301218 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49384134 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47544854 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46433757 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46142591 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45667340 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44968239 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40473872 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40426062 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39611249 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39529544 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38631530 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.34830168 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34375828 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34073537 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33930576 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33332644 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32572338 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32315731 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.32133041 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32119952 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.31572598 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30810982 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29753135 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29092003 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28430136 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27599971 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27533027 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27463323 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26688110 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24968332 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.24763536 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24217942 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24204760 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23757069 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23423536 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23350107 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21854941 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21447838 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20215531 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19568839 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.19445658 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.18878043 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18055093 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17642231 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17440917 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16977256 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15781820 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15389938 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14394162 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14288706 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12981244 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12816915 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12216133 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.11879121 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11715554 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11571579 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10186695 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.10094982 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09494773 |
| 120 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08612722 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08348073 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07950497 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07882115 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.07724465 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.07333255 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.07288898 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06290589 |
| 128 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.05682496 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05530066 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.04957047 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04852022 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.04578864 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04150084 |
| 134 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.03822711 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.03145946 |
| 136 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02909669 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02625739 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.02293797 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.02066240 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.01947453 |
| 141 | Taste transduction_Homo sapiens_hsa04742 | 0.01756391 |

